Newsroom - GILUPI GmbH

Press releases

GILUPI at the 17th World Conference on Lung Cancer

, Medical Technology

GILUPI will participate at the 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria. The WCLC is the world’s largest meeting dedicated...

GILUPI at the 6th Herbsttreffen AG Molekularpathologie

, Medical Technology

At the 6th Herbsttreffen AG Molekularpathologie in Karlsruhe, Germany, from 21th to 22th November 2016, GILUPI will be one of the exhibitors...

Enumeration and molecular characterization of circulating tumor cells in prostate cancer patients using the GILUPI CellCollector®

, Medical Technology

GILUPI GmbH announces the release of clinical data from a prostate cancer setting in August 2016. The scientific paper demonstrate the isolation...

Identification and enumeration of circulating tumor cells in neuroendocrine tumor patients with GILUPI CellCollector®

, Medical Technology

GILUPI GmbH announces, that in August 2016 a published scientific paper demonstrated for the first time circulating tumor cell (CTCs) isolation...

GILUPI GmbH Receives ISO 13485 Certification for Manufacturing and Distribution of Cell Separation Devices

, Medical Technology

After the 68th AACC Annual Scientific Meeting & Clinical Lab Expo (AACC), GILUPI GmbH announces that it has received EN ISO 13485 certification...

GILUPI Strengthens Executive Team - Appoints Dr. Jens Pfannkuche as General Manager

, Medical Technology

GILUPI GmbH, a developer and manufacturer of medical devices to enrich circulating tumor cells (CTCs) in the human blood stream, announces that...

First Chinese patent for GILUPI was granted in March 2016

, Biotechnology

GILUPI GmbH announced today, that the company received the first Chinese patent protecting the unique and innovative GILUPI technology. The patent...

Further European patent was granted in May 2016 - GILUPI detection device for in vivo and/or in vitro enrichment of sample material

, Medical Technology

GILUPI GmbH announced today, that the company received another European patent protecting the unique and innovative GILUPI technology. The patent...

Change in management at GILUPI GmbH

, Medical Technology

With immediate effect, Alexander Herrmann will be responsible as managing director of medical device company, located in Potsdam and Greifswald....

Media

Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
Loading data, please wait...
GILUPI GmbH
Hermannswerder 20a
D - 14473 Potsdam




Social Media Accounts

Contact

Frau Dr. Claudia Chudak


Marketing & Sales Application Specialist

Phone +49 (331) 5818478-5


all contacts

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.